Ryan R. Craig - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & Chief HR Officer
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol: ELV
Transactions as of: 02 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2026, 16:59:14 UTC
Previous filing: 03 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Craig Ryan R	EVP & Chief HR Officer	220 VIRGINIA AVENUE, INDIANAPOLIS	/s/ Kathleen S. Kiefer, Attorney in fact	04 Mar 2026	0002084547

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability		-25	-0.62%	$294.07^*	4,007	02 Mar 2026	Direct	F1
transaction	ELV	Common Stock	Award		+2,976	+74%	$0.000000^*	6,983	02 Mar 2026	Direct	F2
transaction	ELV	Common Stock	Tax liability		-309	-4.4%	$284.03^*	6,674	03 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award		+11,754		$0.000000^*	11,754	02 Mar 2026	Common Stock	11,754	$294.07	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 992 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
F3	The option represents a right to purchase a total of 11,754 shares, and is exercisable in three annual installments, each installment of 3,918 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.